{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:41:42Z","timestamp":1791524502184,"version":"4.3.4"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Post-thrombotic syndrome (PTS) is a common and potentially debilitating complication of deep vein thrombosis (DVT), affecting up to 50% of DVT patients. The consequence of this chronic condition includes reduced quality of life, increased use of the healthcare system and decreased productivity. The societal impact of this condition is projected to increase, given our ageing population and increased burden of thrombotic diseases. Despite significant recent advances in our understanding of PTS, many unanswered questions remain. Currently, there are few effective and proven options for established PTS; hence, the emphasis should be on instituting effective prevention to reduce the progression to PTS. Effective anticoagulation lowers the risk of PTS, with direct oral anticoagulants appearing to outperform vitamin-K antagonists. However, the evidence for elastic compression stockings and endovascular thrombolysis or thrombectomy techniques remains unclear. Accurate identification of individuals at high risk of developing PTS may also improve the targeting of preventative interventions. This review will examine the current body of evidence regarding PTS, with a focus on preventative strategies as well as novel biomarkers.<\/jats:p>","DOI":"10.1007\/s12185-023-03651-6","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T09:02:56Z","timestamp":1693472576000},"page":"547-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Current challenges in the prevention and management of post-thrombotic syndrome\u2014towards improved prevention"],"prefix":"10.1007","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2857-6514","authenticated-orcid":false,"given":"Julie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Smeath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Yin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal","family":"Nandurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Kuan","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prahlad","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"3651_CR1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2009.07601.x","volume":"145","author":"P Prandoni","year":"2009","unstructured":"Prandoni P, Kahn SR. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol. 2009;145:286\u201395.","journal-title":"Br J Haematol"},{"key":"3651_CR2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2019.03.003","volume":"177","author":"YM Ende-Verhaar","year":"2019","unstructured":"Ende-Verhaar YM, Tick LW, Klok FA, Huisman MV, Rosendaal FR, le Cessie S, et al. Post-thrombotic syndrome: short and long-term incidence and risk factors. Thromb Res. 2019;177:102\u20139.","journal-title":"Thromb Res"},{"key":"3651_CR3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/jth.12106","volume":"11","author":"JP Galanaud","year":"2013","unstructured":"Galanaud JP, Holcroft CA, Rodger MA, Kovacs MJ, Betancourt MT, Wells PS, et al. Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency. J Thromb Haemost. 2013;11:474\u201380.","journal-title":"J Thromb Haemost"},{"key":"3651_CR4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1538-7836.2005.01216.x","volume":"3","author":"SR Kahn","year":"2005","unstructured":"Kahn SR, Kearon C, Julian JA, Mackinnon B, Kovacs MJ, Wells P, et al. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemost. 2005;3:718\u201323.","journal-title":"J Thromb Haemost"},{"key":"3651_CR5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1538-7836.2012.04690.x","volume":"10","author":"HS Wik","year":"2012","unstructured":"Wik HS, Jacobsen AF, Sandvik L, Sandset PM. Prevalence and predictors for post-thrombotic syndrome 3 to 16 years after pregnancy-related venous thrombosis: a population-based, cross-sectional, case-control study. J Thromb Haemost. 2012;10:840\u20137.","journal-title":"J Thromb Haemost"},{"key":"3651_CR6","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood-2011-11-391961","volume":"119","author":"P Prandoni","year":"2012","unstructured":"Prandoni P, Noventa F, Quintavalla R, Bova C, Cosmi B, Siragusa S, et al. Thigh-length versus below-knee compression elastic stockings for prevention of the postthrombotic syndrome in patients with proximal-venous thrombosis: a randomized trial. Blood. 2012;119:1561\u20135.","journal-title":"Blood"},{"key":"3651_CR7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-141-4-200408170-00004","volume":"141","author":"P Prandoni","year":"2004","unstructured":"Prandoni P, Lensing AWA, Prins MH, Frulla M, Marchiori A, Bernardi E, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized. Controlled trial. Ann Intern Med. 2004;141:249.","journal-title":"Ann Intern Med"},{"key":"3651_CR8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(96)12215-7","volume":"349","author":"DP Brandjes","year":"1997","unstructured":"Brandjes DP, B\u00fcller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet. 1997;349:759\u201362.","journal-title":"Lancet"},{"key":"3651_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archinte.164.1.17","volume":"164","author":"SR Kahn","year":"2004","unstructured":"Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med. 2004;164:17\u201326.","journal-title":"Arch Intern Med"},{"key":"3651_CR10","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.3324\/haematol.2013.089870","volume":"99","author":"LN Roberts","year":"2014","unstructured":"Roberts LN, Patel RK, Donaldson N, Bonner L, Arya R. Post-thrombotic syndrome is an independent determinant of health-related quality of life following both first proximal and distal deep vein thrombosis. Haematologica. 2014;99:e41\u20133.","journal-title":"Haematologica"},{"key":"3651_CR11","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archinte.162.10.1144","volume":"162","author":"SR Kahn","year":"2002","unstructured":"Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med. 2002;162:1144\u20138.","journal-title":"Arch Intern Med"},{"key":"3651_CR12","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/j.1538-7836.2004.00957.x","volume":"2","author":"SR Kahn","year":"2004","unstructured":"Kahn SR, M\u2019Lan CE, Lamping DL, Kurz X, B\u00e9rard A, Abenhaim L, et al. The influence of venous thromboembolism on quality of life and severity of chronic venous disease. J Thromb Haemost. 2004;2:2146\u201351.","journal-title":"J Thromb Haemost"},{"key":"3651_CR13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1538-7836.2008.03002.x","volume":"6","author":"SR Kahn","year":"2008","unstructured":"Kahn SR, Shbaklo H, Lamping DL, Holcroft CA, Shrier I, Miron MJ, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost. 2008;6:1105\u201312.","journal-title":"J Thromb Haemost"},{"key":"3651_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2015.11.033","volume":"137","author":"SD Grosse","year":"2016","unstructured":"Grosse SD, Nelson RE, Nyarko KA, Richardson LC, Raskob GE. The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs. Thromb Res. 2016;137:3\u201310.","journal-title":"Thromb Res"},{"key":"3651_CR15","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1111\/j.1538-7836.2011.04516.x","volume":"9","author":"R Guanella","year":"2011","unstructured":"Guanella R, Ducruet T, Johri M, Miron M-J, Roussin A, Desmarais S, et al. Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost. 2011;9:2397\u2013405.","journal-title":"J Thromb Haemost"},{"key":"3651_CR16","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","volume":"118","author":"AM Wendelboe","year":"2016","unstructured":"Wendelboe AM, Raskob GE. Global burden of thrombosis. Circ Res. 2016;118:1340\u20137.","journal-title":"Circ Res"},{"key":"3651_CR17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","volume":"2016","author":"SR Kahn","year":"2016","unstructured":"Kahn SR. The post-thrombotic syndrome. Hematology. 2016;2016:413\u20138.","journal-title":"Hematology"},{"key":"3651_CR18","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S0049-3848(09)70146-X","volume":"123","author":"S Vedantham","year":"2009","unstructured":"Vedantham S. Valvular dysfunction and venous obstruction in the post-thrombotic syndrome. Thromb Res. 2009;123:S62\u20135.","journal-title":"Thromb Res"},{"key":"3651_CR19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMra055289","volume":"355","author":"JJ Bergan","year":"2006","unstructured":"Bergan JJ, Schmid-Sch\u00f6nbein GW, Smith PDC, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. New Engl J Medicine. 2006;355:488\u201398.","journal-title":"New Engl J Medicine"},{"key":"3651_CR20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1067\/mva.2003.66","volume":"37","author":"AG Passerini","year":"2003","unstructured":"Passerini AG, Milsted A, Rittgers SE. Shear stress magnitude and directionality modulate growth factor gene expression in preconditioned vascular endothelial cells. J Vasc Surg. 2003;37:182\u201390.","journal-title":"J Vasc Surg"},{"key":"3651_CR21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejvs.2004.05.012","volume":"28","author":"S Takase","year":"2004","unstructured":"Takase S, Pascarella L, Lerond L, Bergan JJ, Schmid-Sch\u00f6nbein GW. Venous hypertension, inflammation and valve remodeling. Eur J Vasc Endovasc. 2004;28:484\u201393.","journal-title":"Eur J Vasc Endovasc"},{"key":"3651_CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/joim.12465","volume":"280","author":"JM Tarbell","year":"2016","unstructured":"Tarbell JM, Cancel LM. The glycocalyx and its significance in human medicine. J Intern Med. 2016;280:97\u2013113.","journal-title":"J Intern Med"},{"key":"3651_CR23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.avsg.2017.06.131","volume":"46","author":"R Castro-Ferreira","year":"2018","unstructured":"Castro-Ferreira R, Cardoso R, Leite-Moreira A, Mansilha A. The role of endothelial dysfunction and inflammation in chronic venous disease. Ann Vasc Surg. 2018;46:380\u201393.","journal-title":"Ann Vasc Surg"},{"key":"3651_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jvs.2010.07.043","volume":"53","author":"KB Deatrick","year":"2011","unstructured":"Deatrick KB, Elfline M, Baker N, Luke CE, Blackburn S, Stabler C, et al. Postthrombotic vein wall remodeling: Preliminary observations. J Vasc Surg. 2011;53:139\u201346.","journal-title":"J Vasc Surg"},{"key":"3651_CR25","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/jth.13793","volume":"15","author":"A Chandrashekar","year":"2017","unstructured":"Chandrashekar A, Garry J, Gasparis A, Labropoulos N. Vein wall remodeling in patients with acute deep vein thrombosis and chronic postthrombotic changes. J Thromb Haemost. 2017;15:1989\u201393.","journal-title":"J Thromb Haemost"},{"key":"3651_CR26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1160\/TH13-11-0931","volume":"111","author":"A Rabinovich","year":"2014","unstructured":"Rabinovich A, Cohen JM, Kahn SR. The predictive value of markers of fibrinolysis and endothelial dysfunction in the post thrombotic syndrome. Thromb Haemostasis. 2014;111:1031\u201340.","journal-title":"Thromb Haemostasis"},{"key":"3651_CR27","first-page":"1130","volume":"24","author":"PK Henke","year":"2004","unstructured":"Henke PK, Varga A, De S, Deatrick CB, Eliason J, Arenberg DA, et al. Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model. Arteriosclerosis Thrombosis Vasc Biology. J Am Hear Assoc. 2004;24:1130\u20137.","journal-title":"J Am Hear Assoc"},{"key":"3651_CR28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1160\/TH05-02-0099","volume":"95","author":"PK Henke","year":"2006","unstructured":"Henke PK, Varma MR, Deatrick KB, Dewyer NA, Drewyer NA, Lynch EM, et al. Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization. Thromb Haemostasis. 2006;95:272\u201381.","journal-title":"Thromb Haemostasis"},{"key":"3651_CR29","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191865","volume":"217","author":"SK Baker","year":"2020","unstructured":"Baker SK, Strickland S. A critical role for plasminogen in inflammation. J Exp Med. 2020;217: e20191865.","journal-title":"J Exp Med"},{"key":"3651_CR30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jvs.2005.04.014","volume":"42","author":"KB Deatrick","year":"2005","unstructured":"Deatrick KB, Eliason JL, Lynch EM, Moore AJ, Dewyer NA, Varma MR, et al. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg. 2005;42:140\u20138.","journal-title":"J Vasc Surg"},{"key":"3651_CR31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/ATVBAHA.108.162289","volume":"28","author":"TW Wakefield","year":"2008","unstructured":"Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arteriosclerosis Thrombosis Vasc Biol. 2008;28:387\u201391.","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"key":"3651_CR32","volume":"10","author":"KP Nguyen","year":"2015","unstructured":"Nguyen KP, McGilvray KC, Puttlitz CM, Mukhopadhyay S, Chabasse C, Sarkar R. Matrix Metalloproteinase 9 (MMP-9) regulates vein wall biomechanics in murine thrombus resolution. PLoS ONE. 2015;10: e0139145.","journal-title":"PLoS ONE"},{"key":"3651_CR33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.thromres.2013.06.027","volume":"132","author":"KB Deatrick","year":"2013","unstructured":"Deatrick KB, Obi A, Luke CE, Elfline MA, Sood V, Upchurch GR, et al. Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT. Thromb Res. 2013;132:360\u20136.","journal-title":"Thromb Res"},{"key":"3651_CR34","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/jth.12644","volume":"12","author":"AT Obi","year":"2014","unstructured":"Obi AT, Diaz JA, Ballard-Lipka NL, Roelofs KJ, Farris DM, Lawrence DA, et al. Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism. J Thromb Haemost. 2014;12:1353\u201363.","journal-title":"J Thromb Haemost"},{"key":"3651_CR35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1160\/TH10-03-0183","volume":"104","author":"S DeRoo","year":"2010","unstructured":"DeRoo S, Deatrick KB, Henke P. The vessel wall: a forgotten player in post thrombotic syndrome. Thromb Haemostasis. 2010;104:681\u201392.","journal-title":"Thromb Haemostasis"},{"key":"3651_CR36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/17474086.2019.1627193","volume":"12","author":"A Undas","year":"2019","unstructured":"Undas A, Natorska J. Improving fibrinolysis in venous thromboembolism: impact of fibrin structure. Expert Rev Hematol. 2019;12:597\u2013607.","journal-title":"Expert Rev Hematol"},{"key":"3651_CR37","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/j.1538-7836.2008.03180.x","volume":"6","author":"LW Tick","year":"2008","unstructured":"Tick LW, Kramer MHH, Rosendaal FR, Faber WR, Doggen CJM. Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis. J Thromb Haemost. 2008;6:2075\u201381.","journal-title":"J Thromb Haemost"},{"key":"3651_CR38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0037-1613447","volume":"89","author":"W Ageno","year":"2003","unstructured":"Ageno W, Piantanida E, Dentali F, Steidl L, Mera V, Squizzato A, et al. Body mass index is associated with the development of the post-thrombotic syndrome. Thromb Haemostasis. 2003;89:305\u20139.","journal-title":"Thromb Haemostasis"},{"key":"3651_CR39","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/bjh.12192","volume":"160","author":"LN Roberts","year":"2013","unstructured":"Roberts LN, Patel RK, Chitongo PB, Bonner L, Arya R. Presenting D-dimer and early symptom severity are independent predictors for post-thrombotic syndrome following a first deep vein thrombosis. Brit J Haematol. 2013;160:817\u201324.","journal-title":"Brit J Haematol"},{"key":"3651_CR40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jvsv.2015.07.008","volume":"4","author":"LN Roberts","year":"2016","unstructured":"Roberts LN, Patel RK, Goss DE, Chitongo P, Bonner L, Arya R. Relationship between development of post-thrombotic syndrome and serial ultrasound, D-dimer, and factor VIII activity after a first deep venous thrombosis. J Vasc Surg Venous Lymphatic Disord. 2016;4:28\u201335.","journal-title":"J Vasc Surg Venous Lymphatic Disord"},{"key":"3651_CR41","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1538-7836.2005.01333.x","volume":"3","author":"CJJ Dongen","year":"2005","unstructured":"Dongen CJJ, Prandoni P, Frulla M, Marchiori A, Prins MH, Hutten BA. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost. 2005;3:939\u201342.","journal-title":"J Thromb Haemost"},{"key":"3651_CR42","doi-asserted-by":"crossref","unstructured":"Rabinovich A, Ducruet T, Kahn SR, et al. Development of a clinical prediction model for the postthrombotic syndrome in a prospective cohort of patients with proximal deep vein thrombosis. J Thromb Haemost. 2018;16: 262\u201370.","DOI":"10.1111\/jth.13909"},{"key":"3651_CR43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jth.12447","volume":"12","author":"A Rabinovich","year":"2014","unstructured":"Rabinovich A, Cohen JM, Prandoni P, Kahn SR. Association between thrombophilia and the post-thrombotic syndrome: a systematic review and meta-analysis. J Thromb Haemost. 2014;12:14\u201323.","journal-title":"J Thromb Haemost"},{"key":"3651_CR44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0609.2011.01733.x","volume":"88","author":"P Prandoni","year":"2012","unstructured":"Prandoni P. Healthcare burden associated with the post-thrombotic syndrome and potential impact of the new oral anticoagulants. Eur J Haematol. 2012;88:185\u201394.","journal-title":"Eur J Haematol"},{"key":"3651_CR45","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jvs.2012.09.011","volume":"57","author":"A Soosainathan","year":"2013","unstructured":"Soosainathan A, Moore HM, Gohel MS, Davies AH. Scoring systems for the post-thrombotic syndrome. J Vasc Surg. 2013;57:254\u201361.","journal-title":"J Vasc Surg"},{"key":"3651_CR46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2017.10.022","volume":"164","author":"HS Wik","year":"2018","unstructured":"Wik HS, Enden TR, Ghanima W, Engeseth M, Kahn SR, Sandset PM. Diagnostic scales for the post-thrombotic syndrome. Thromb Res. 2018;164:110\u20135.","journal-title":"Thromb Res"},{"key":"3651_CR47","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.thromres.2016.06.032","volume":"144","author":"M Milan","year":"2016","unstructured":"Milan M, Sarolo L, Callegari E, Vedovetto V, Villalta S, Prandoni P. High rate of inter-observer agreement between professional-rated scores of the Villalta scale for the assessment of the post-thrombotic syndrome. Thromb Res. 2016;144:182\u20133.","journal-title":"Thromb Res"},{"key":"3651_CR48","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1538-7836.2009.03339.x","volume":"7","author":"SR Kahn","year":"2009","unstructured":"Kahn SR. Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome. J Thromb Haemost. 2009;7:884\u20138.","journal-title":"J Thromb Haemost"},{"key":"3651_CR49","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000000130","volume":"130","author":"SR Kahn","year":"2014","unstructured":"Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies. Circulation. 2014;130:1636\u201361.","journal-title":"Circulation"},{"key":"3651_CR50","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1055\/a-1171-0486","volume":"40","author":"G Gautam","year":"2020","unstructured":"Gautam G, Sebastian T, Klok FA. How to differentiate recurrent deep vein thrombosis from postthrombotic syndrome. Hamostaseologie. 2020;40:280\u201391.","journal-title":"Hamostaseologie"},{"key":"3651_CR51","first-page":"135886","volume":"1","author":"M M\u00fcller","year":"2023","unstructured":"M\u00fcller M, Wolf F, Loewe C, Beitzke D, Zehetmayer S, Gschwandtner ME, et al. Preprocedural imaging modalities in patients undergoing iliocaval venous recanalization and stent placement. Vasc Med. 2023;1:135886.","journal-title":"Vasc Med."},{"key":"3651_CR52","first-page":"20170005","volume":"91","author":"VG Helyar","year":"2018","unstructured":"Helyar VG, Gupta Y, Blakeway L, Charles-Edwards G, Katsanos K, Karunanithy N. Depiction of lower limb venous anatomy in patients undergoing interventional deep venous reconstruction\u2014the role of balanced steady state free precession MRI. Br J Radiology. 2018;91:20170005.","journal-title":"Br J Radiology"},{"key":"3651_CR53","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood.2019004114","volume":"135","author":"LF van Dam","year":"2020","unstructured":"van Dam LF, Dronkers CEA, Gautam G, Eckerbom \u00c5, Ghanima W, Gleditsch J, et al. Magnetic resonance imaging for diagnosis of recurrent ipsilateral deep vein thrombosis. Blood. 2020;135:1377\u201385.","journal-title":"Blood"},{"key":"3651_CR54","first-page":"1","volume":"1","author":"I Makedonov","year":"2021","unstructured":"Makedonov I, Kahn SR, Abdulrehman J, Schulman S, Delluc A, Gross P, et al. Prevention of the postthrombotic syndrome with anticoagulation: a narrative review. Thromb Haemostasis. 2021;1:1.","journal-title":"Thromb Haemostasis."},{"key":"3651_CR55","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bjh.16275","volume":"188","author":"C Bradbury","year":"2020","unstructured":"Bradbury C, Fletcher K, Sun Y, Heneghan C, Gardiner C, Roalfe A, et al. A randomised controlled trial of extended anticoagulation treatment versusstandard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study). Br J Haematol. 2020;188:962\u201375.","journal-title":"Br J Haematol"},{"key":"3651_CR56","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1538-7836.2012.04872.x","volume":"10","author":"RS Chitsike","year":"2012","unstructured":"Chitsike RS, Rodger MA, Kovacs MJ, Betancourt MT, Wells PS, Anderson DR, et al. Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study. J Thromb Haemost. 2012;10:2039\u201344.","journal-title":"J Thromb Haemost"},{"key":"3651_CR57","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.amjmed.2018.01.041","volume":"131","author":"M S\u00f8gaard","year":"2018","unstructured":"S\u00f8gaard M, Nielsen PB, Skj\u00f8th F, Kj\u00e6ldgaard JN, Coleman CI, Larsen TB. Rivaroxaban versus warfarin and risk of post-thrombotic syndrome among patients with venous thromboembolism. Am J Medicine. 2018;131:787-794.e4.","journal-title":"Am J Medicine"},{"key":"3651_CR58","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.amjmed.2008.12.023","volume":"122","author":"RD Hull","year":"2009","unstructured":"Hull RD, Pineo GF, Brant R, Liang J, Cook R, Solymoss S, et al. Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome. Am J Med. 2009;122:762-769.e3.","journal-title":"Am J Med"},{"key":"3651_CR59","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jvs.2008.05.033","volume":"48","author":"JA Gonz\u00e1lez-Fajardo","year":"2008","unstructured":"Gonz\u00e1lez-Fajardo JA, Martin-Pedrosa M, Castrodeza J, Tamames S, Vaquero-Puerta C. Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: comparative study of enoxaparin versus coumarin. J Vasc Surg. 2008;48:953-959.e2.","journal-title":"J Vasc Surg"},{"key":"3651_CR60","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ejvs.2004.02.029","volume":"29","author":"ME Daskalopoulos","year":"2005","unstructured":"Daskalopoulos ME, Daskalopoulou SS, Tzortzis E, Sfiridis P, Nikolaou A, Dimitroulis D, et al. Long-term treatment of deep venous thrombosis with a low molecular weight heparin (Tinzaparin): a prospective randomized trial. Eur J Vasc Endovasc. 2005;29:638\u201350.","journal-title":"Eur J Vasc Endovasc"},{"key":"3651_CR61","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejvs.2008.11.030","volume":"37","author":"A Romera","year":"2009","unstructured":"Romera A, Cairols MA, Vila-Coll R, Mart\u00ed X, Colom\u00e9 E, Bonell A, et al. A RANDOMISED OPEN-LABEL TRIAL COMPARING LONG-TERM SUB-CUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN COMPARED WITH ORAL-ANTICOAGULANT THERAPY IN THE TREATMENT OF DEEP VENOUS THROMBOSIS. Eur J Vasc Endovasc. 2009;37:349\u201356.","journal-title":"Eur J Vasc Endovasc"},{"key":"3651_CR62","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1160\/TH16-08-0620","volume":"117","author":"TJ Poterucha","year":"2017","unstructured":"Poterucha TJ, Libby P, Goldhaber SZ. More than an anticoagulant: do heparins have direct anti-inflammatory effects? Thromb Haemostasis. 2017;117:437\u201344.","journal-title":"Thromb Haemostasis"},{"key":"3651_CR63","unstructured":"Association EWM. Understanding compression therapy: Position document."},{"key":"3651_CR64","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jvs.2011.07.071","volume":"55","author":"G Mosti","year":"2012","unstructured":"Mosti G, Iabichella ML, Partsch H. Compression therapy in mixed ulcers increases venous output and arterial perfusion. J Vasc Surg. 2012;55:122\u20138.","journal-title":"J Vasc Surg"},{"key":"3651_CR65","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(13)61902-9","volume":"383","author":"SR Kahn","year":"2014","unstructured":"Kahn SR, Shapiro S, Wells PS, Rodger MA, Kovacs MJ, Anderson DR, et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet. 2014;383:880\u20138.","journal-title":"Lancet"},{"key":"3651_CR66","doi-asserted-by":"crossref","first-page":"e886","DOI":"10.1016\/S2352-3026(22)00247-2","volume":"9","author":"J-P Galanaud","year":"2022","unstructured":"Galanaud J-P, Genty-Vermorel C, Barrellier M-T, Becker F, Jabbour V, Blaise S, et al. 25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial. Lancet Haematol. 2022;9:e886\u201396.","journal-title":"Lancet Haematol"},{"key":"3651_CR67","volume":"353","author":"GC Mol","year":"2016","unstructured":"Mol GC, van de Ree MA, Klok FA, Tegelberg MJAM, Sanders FBM, Koppen S, et al. One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomised controlled trial. BMJ. 2016;353: i2691.","journal-title":"BMJ"},{"key":"3651_CR68","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/S2352-3026(17)30227-2","volume":"5","author":"AJ ten Cate-Hoek","year":"2018","unstructured":"ten Cate-Hoek AJ, Amin EE, Bouman AC, Meijer K, Tick LW, Middeldorp S, et al. Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial. Lancet Haematol. 2018;5:e25-33.","journal-title":"Lancet Haematol"},{"key":"3651_CR69","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","volume":"4","author":"TL Ortel","year":"2020","unstructured":"Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4:4693\u2013738.","journal-title":"Blood Adv"},{"key":"3651_CR70","doi-asserted-by":"crossref","unstructured":"Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Elsevier Inc; 2016.","DOI":"10.1016\/j.chest.2015.11.026"},{"key":"3651_CR71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)61753-4","volume":"379","author":"T Enden","year":"2012","unstructured":"Enden T, Haig Y, Kl\u00f8w N-E, Slagsvold C-E, Sandvik L, Ghanima W, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379:31\u20138.","journal-title":"Lancet"},{"key":"3651_CR72","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S2352-3026(15)00248-3","volume":"3","author":"Y Haig","year":"2016","unstructured":"Haig Y, Enden T, Gr\u00f8tta O, Kl\u00f8w N-E, Slagsvold C-E, Ghanima W, et al. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol. 2016;3:e64-71.","journal-title":"Lancet Haematol"},{"key":"3651_CR73","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/S2352-3026(19)30209-1","volume":"7","author":"P Notten","year":"2020","unstructured":"Notten P, ten Cate-Hoek AJ, Arnoldussen CWKP, Strijkers RHW, de Smet AAEA, Tick LW, et al. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. Lancet Haematol. 2020;7:e40\u20139.","journal-title":"Lancet Haematol"},{"key":"3651_CR74","doi-asserted-by":"crossref","first-page":"e018973","DOI":"10.1161\/JAHA.120.018973","volume":"10","author":"P Notten","year":"2020","unstructured":"Notten P, de Smet AAEA, Tick LW, van de Poel MHW, Wikkeling ORM, Vleming L, et al. CAVA (Ultrasound-Accelerated Catheter-Directed Thrombolysis on Preventing Post-Thrombotic Syndrome) Trial: Long-Term Follow-Up Results. J Am Heart Assoc. 2020;10:e018973.","journal-title":"J Am Heart Assoc"},{"key":"3651_CR75","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa1615066","volume":"377","author":"S Vedantham","year":"2017","unstructured":"Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. New Engl J Med. 2017;377:2240\u201352.","journal-title":"New Engl J Med"},{"key":"3651_CR76","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0039-1677795","volume":"119","author":"C Kearon","year":"2019","unstructured":"Kearon C, Gu C-S, Julian J, Goldhaber S, Comerota A, Gornik H, et al. Pharmacomechanical catheter-directed thrombolysis in acute femoral-popliteal deep vein thrombosis: analysis from a stratified randomized trial. Thromb Haemostasis. 2019;119:633\u201344.","journal-title":"Thromb Haemostasis"},{"key":"3651_CR77","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/1358863X19862043","volume":"24","author":"I Weinberg","year":"2019","unstructured":"Weinberg I, Vedantham S, Salter A, Hadley G, Al-Hammadi N, Kearon C, et al. Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial. Vasc Med. 2019;24:442\u201351.","journal-title":"Vasc Med"},{"key":"3651_CR78","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.120.049096","volume":"143","author":"W Li","year":"2020","unstructured":"Li W, Kessinger CW, Orii M, Lee H, Wang L, Weinberg I, et al. Time-restricted salutary effects of blood flow restoration on venous thrombosis and vein wall injury in mouse and human subjects. Circulation. 2020;143:1224\u201338.","journal-title":"Circulation"},{"key":"3651_CR79","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","volume":"360","author":"RJ Glynn","year":"2009","unstructured":"Glynn RJ, Danielson E, Fonseca FAH, Genest J, Gotto AM, Kastelein JJP, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. New Engl J Med. 2009;360:1851\u201361.","journal-title":"New Engl J Med"},{"key":"3651_CR80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2022.03.014","volume":"213","author":"A Delluc","year":"2022","unstructured":"Delluc A, Ghanima W, Kovacs MJ, Shivakumar S, Kahn SR, Sandset PM, et al. Prevention of post-thrombotic syndrome with rosuvastatin: a multicenter randomized controlled pilot trial (SAVER). Thromb Res. 2022;213:119\u201324.","journal-title":"Thromb Res"},{"key":"3651_CR81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/DDDT.S6762","volume":"8","author":"S Coccheri","year":"2013","unstructured":"Coccheri S, Mannello F. Development and use of sulodexide in vascular diseases: implications for treatment. Drug Des Dev Ther. 2013;8:49\u201365.","journal-title":"Drug Des Dev Ther"},{"key":"3651_CR82","doi-asserted-by":"crossref","unstructured":"Palareti G, Barinov V, Urbanek T, Cini M, Li Y-J, Bouslama K, et al. Recurrences and bleeding during extended treatment of patients with venous thromboembolism: results of the international, prospective, observational WHITE study. Int Angiol. 2023.","DOI":"10.23736\/S0392-9590.22.04970-7"},{"key":"3651_CR83","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.115.016930","volume":"132","author":"GM Andreozzi","year":"2015","unstructured":"Andreozzi GM, Bignamini AA, Dav\u00ec G, Palareti G, Matu\u0161ka J, Hol\u00fd M, et al. Sulodexide for the prevention of recurrent venous thromboembolism. Circulation. 2015;132:1891\u20137.","journal-title":"Circulation"},{"key":"3651_CR84","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/1076029614533143","volume":"20","author":"R Luzzi","year":"2014","unstructured":"Luzzi R, Belcaro G, Dugall M, Hu S, Arpaia G, Ledda A, et al. The efficacy of sulodexide in the prevention of postthrombotic syndrome. Clin Appl Thrombosis Hemostasis. 2014;20:594\u20139.","journal-title":"Clin Appl Thrombosis Hemostasis"},{"key":"3651_CR85","doi-asserted-by":"crossref","unstructured":"Martinez\u2010Zapata MJ, Vernooij RW, Tuma SMU, Stein AT, Moreno RM, Vargas E, et al. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev. 2016;4:003229.","DOI":"10.1002\/14651858.CD003229.pub3"},{"key":"3651_CR86","doi-asserted-by":"crossref","first-page":"361","DOI":"10.23736\/S0392-9590.20.04356-4","volume":"39","author":"I Schastlivtsev","year":"2020","unstructured":"Schastlivtsev I, Lobastov K, Barinov V, Kanzafarova I. Diosmin 600 in adjunction to rivaroxaban reduces the risk of post-thrombotic syndrome after femoropopliteal deep vein thrombosis: results of the RIDILOTT DVT study. Int Angiol. 2020;39:361\u201371.","journal-title":"Int Angiol"},{"key":"3651_CR87","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049557","volume":"11","author":"JP Galanaud","year":"2021","unstructured":"Galanaud JP, Abdulrehman J, Lazo-Langner A, Gal GL, Shivakumar S, Schulman S, et al. MUFFIN-PTS trial, Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome: protocol of a randomised controlled trial. BMJ Open. 2021;11: e049557.","journal-title":"BMJ Open"},{"key":"3651_CR88","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0268355516689631","volume":"33","author":"E Rabe","year":"2018","unstructured":"Rabe E, Partsch H, Hafner J, Lattimer C, Mosti G, Neumann M, et al. Indications for medical compression stockings in venous and lymphatic disorders: an evidence-based consensus statement. Phlebology. 2018;33:163\u201384.","journal-title":"Phlebology"},{"key":"3651_CR89","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/archinte.161.17.2105","volume":"161","author":"JS Ginsberg","year":"2001","unstructured":"Ginsberg JS, Hirsh J, Julian J, LaandeVries MV, Magier D, MacKinnon B, et al. Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med. 2001;161:2105\u20139.","journal-title":"Arch Intern Med"},{"key":"3651_CR90","doi-asserted-by":"crossref","unstructured":"Azirar S, Appelen D, Prins MH, Neumann MH, Feiter AN, Kolbach DN. Compression therapy for treating post\u2010thrombotic syndrome. Cochrane Db Syst Rev. 2019;2019:CD004177.","DOI":"10.1002\/14651858.CD004177.pub2"},{"key":"3651_CR91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1503\/cmaj.100248","volume":"183","author":"SR Kahn","year":"2011","unstructured":"Kahn SR, Shrier I, Shapiro S, Houweling AH, Hirsch AM, Reid RD, et al. Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial. Can Med Assoc J. 2011;183:37\u201344.","journal-title":"Can Med Assoc J"},{"key":"3651_CR92","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jvs.2003.09.036","volume":"39","author":"FT Padberg","year":"2004","unstructured":"Padberg FT, Johnston MV, Sisto SA. Structured exercise improves calf muscle pump function in chronic venous insufficiency: a randomized trial. J Vasc Surg. 2004;39:79\u201387.","journal-title":"J Vasc Surg"},{"key":"3651_CR93","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jvsv.2020.10.016","volume":"9","author":"M Sharifi","year":"2021","unstructured":"Sharifi M, Bay RC, Karandish K, Emrani F, Snyder R, D\u2019Silva S, et al. The randomized, controlled ATLANTIS trial of aquatic therapy for chronic venous insufficiency. J Vasc Surg Venous Lymphatic Disord. 2021;9:961\u201370.","journal-title":"J Vasc Surg Venous Lymphatic Disord"},{"key":"3651_CR94","doi-asserted-by":"crossref","unstructured":"Morling JR, Broderick C, Yeoh SE, Kolbach DN. Rutosides for treatment of post\u2010thrombotic syndrome. Cochrane Db Syst Rev. 2018;2018:CD005625.","DOI":"10.1002\/14651858.CD005625.pub4"},{"key":"3651_CR95","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s12325-020-01232-1","volume":"37","author":"AA Bignamini","year":"2020","unstructured":"Bignamini AA, Matu\u0161ka J. Sulodexide for the symptoms and signs of chronic venous disease: a systematic review and meta-analysis. Adv Ther. 2020;37:1013\u201333.","journal-title":"Adv Ther"},{"key":"3651_CR96","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/jth.14324","volume":"17","author":"BJ Carroll","year":"2019","unstructured":"Carroll BJ, Piazza G, Goldhaber SZ. Sulodexide in venous disease. J Thromb Haemost. 2019;17:31\u20138.","journal-title":"J Thromb Haemost"},{"key":"3651_CR97","first-page":"e002772","volume":"8","author":"MK Razavi","year":"2018","unstructured":"Razavi MK, Jaff MR, Miller LE. Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction. Circulation Cardiovasc Interventions. 2018;8:e002772.","journal-title":"Circulation Cardiovasc Interventions"},{"key":"3651_CR98","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1055\/s-0039-1697955","volume":"119","author":"T Sebastian","year":"2019","unstructured":"Sebastian T, Spirk D, Engelberger R, Dopheide J, Baumann F, Barco S, et al. Incidence of stent thrombosis after endovascular treatment of iliofemoral or caval veins in patients with the postthrombotic syndrome. Thromb Haemostasis. 2019;119:2064\u201373.","journal-title":"Thromb Haemostasis"},{"key":"3651_CR99","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1148\/radiol.2015132603","volume":"276","author":"AK Sista","year":"2015","unstructured":"Sista AK, Vedantham S, Kaufman JA, Madoff DC. Endovascular interventions for acute and chronic lower extremity deep venous disease: state of the art. Radiology. 2015;276:31\u201353.","journal-title":"Radiology"},{"key":"3651_CR100","doi-asserted-by":"crossref","unstructured":"Masuda EM, Kistner RL, Honolulu. F the D of VS Straub Clinic and Hospital Long-term results of venous valve reconstruction: a four- to twenty-one\u2014year follow-up. J Vasc Surg. 1994;19:391\u2013403.","DOI":"10.1016\/S0741-5214(94)70066-4"},{"key":"3651_CR101","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/15385744211073730","volume":"56","author":"JH Ulloa","year":"2022","unstructured":"Ulloa JH, Glickman M. One-year first-in-human success for venovalve in treating patients with severe deep venous insufficiency. Vasc Endovasc Surg. 2022;56:277\u201383.","journal-title":"Vasc Endovasc Surg"},{"key":"3651_CR102","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1055\/s-0038-1666859","volume":"118","author":"CEA Dronkers","year":"2018","unstructured":"Dronkers CEA, Mol GC, Maraziti G, van de Ree MA, Huisman MV, Becattini C, et al. Predicting post-thrombotic syndrome with ultrasonographic follow-up after deep vein thrombosis: a systematic review and meta-analysis. Thromb Haemostasis. 2018;118:1428\u201338.","journal-title":"Thromb Haemostasis"},{"key":"3651_CR103","doi-asserted-by":"crossref","first-page":"e25809","DOI":"10.1097\/MD.0000000000025809","volume":"100","author":"C-W Chen","year":"2021","unstructured":"Chen C-W, Ting H, Chen P-Y, Weng J-C, Hsu Y-C, Wang S-C, et al. Usefulness of triggered non-contrast-enhanced magnetic resonance angiography in assessing lower extremity venous disease. Medicine. 2021;100:e25809.","journal-title":"Medicine"},{"key":"3651_CR104","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.thromres.2015.06.024","volume":"136","author":"A Rabinovich","year":"2015","unstructured":"Rabinovich A, Cohen JM, Kahn SR. Predictive value of markers of inflammation in the postthrombotic syndrome: a systematic review Inflammatory biomarkers and PTS. Thromb Res. 2015;136:289\u201397.","journal-title":"Thromb Res"},{"key":"3651_CR105","doi-asserted-by":"crossref","unstructured":"Bittar LF, Silva LQ, Orsi FL, Zapponi KCS, Mazetto B, Paula EV, et al. Increased inflammation and endothelial markers in patients with late severe post-thrombotic syndrome. Plos ONE. 2020;15:e0227150.","DOI":"10.1371\/journal.pone.0227150"},{"key":"3651_CR106","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/16078454.2019.1687144","volume":"24","author":"D Borgel","year":"2019","unstructured":"Borgel D, Bianchini E, Lasne D, Pascreau T, Saller F. Inflammation in deep vein thrombosis: a therapeutic target? Hematology. 2019;24:742\u201350.","journal-title":"Hematology"},{"key":"3651_CR107","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1160\/TH08-08-0511","volume":"101","author":"H Shbaklo","year":"2009","unstructured":"Shbaklo H, Holcroft CA, Kahn SR. Levels of inflammatory markers and the development of the post-thrombotic syndrome. Thromb Haemostasis. 2009;101:505\u201312.","journal-title":"Thromb Haemostasis"},{"key":"3651_CR108","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.thromres.2015.12.014","volume":"138","author":"HS Wik","year":"2016","unstructured":"Wik HS, Jacobsen AF, Mowinckel M-C, Sandset PM. The role of inflammation in post-thrombotic syndrome after pregnancy-related deep vein thrombosis: a population-based, cross-sectional study. Thromb Res. 2016;138:16\u201321.","journal-title":"Thromb Res"},{"key":"3651_CR109","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/jth.12814","volume":"13","author":"A Rabinovich","year":"2015","unstructured":"Rabinovich A, Cohen JM, Cushman M, Wells PS, Rodger MA, Kovacs MJ, et al. Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome. J Thromb Haemost. 2015;13:398\u2013408.","journal-title":"J Thromb Haemost"},{"key":"3651_CR110","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/iwj.12489","volume":"13","author":"S Franciscis","year":"2016","unstructured":"Franciscis S, Gallelli L, Amato B, Butrico L, Rossi A, Buffone G, et al. Plasma MMP and TIMP evaluation in patients with deep venous thrombosis: could they have a predictive role in the development of post-thrombotic syndrome? Int Wound J. 2016;13:1237\u201345.","journal-title":"Int Wound J"},{"key":"3651_CR111","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1538-7836.2012.04798.x","volume":"10","author":"AC Bouman","year":"2012","unstructured":"Bouman AC, Smits JJM, Cate HT, Cate-Hoek AJT. Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome. J Thromb Haemost. 2012;10:1532\u20138.","journal-title":"J Thromb Haemost"},{"key":"3651_CR112","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/jth.13264","volume":"14","author":"J Siudut","year":"2016","unstructured":"Siudut J, Grela M, Wypasek E, Plens K, Undas A. Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome. J Thromb Haemost. 2016;14:784\u201393.","journal-title":"J Thromb Haemost"},{"key":"3651_CR113","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1038\/s41598-018-25135-y","volume":"8","author":"S Mrozinska","year":"2018","unstructured":"Mrozinska S, Cieslik J, Broniatowska E, Undas A. Elevated leptin and decreased adiponectin independently predict the post-thrombotic syndrome in obese and non-obese patients. Sci Rep-uk. 2018;8:6938.","journal-title":"Sci Rep-uk"},{"key":"3651_CR114","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.thromres.2014.06.010","volume":"134","author":"AC Bouman","year":"2014","unstructured":"Bouman AC, Cheung YW, Spronk HM, Schalkwijk CG, ten Cate H, ten Wolde M, et al. Biomarkers for post thrombotic syndrome: a case-control study. Thromb Res. 2014;134:369\u201375.","journal-title":"Thromb Res"},{"key":"3651_CR115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.thromres.2014.12.024","volume":"135","author":"LF Bittar","year":"2015","unstructured":"Bittar LF, Mazetto B, Orsi FLA, Collela MP, Paula EVD, Annichino-Bizzacchi JM. Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis. Thromb Res. 2015;135:497\u2013501.","journal-title":"Thromb Res."},{"key":"3651_CR116","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.3390\/diagnostics12123165","volume":"12","author":"B McLeod","year":"2022","unstructured":"McLeod B, Lim HY, Nandurkar H, Ho P, Wang J. Overall hemostatic potential assay detects risk of progression to post-thrombotic syndrome in anticoagulated patients following deep vein thrombosis. Diagnostics. 2022;12:3165.","journal-title":"Diagnostics"},{"key":"3651_CR117","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11239-022-02686-6","volume":"55","author":"J Wang","year":"2022","unstructured":"Wang J, Lim HY, Brook R, Lai J, Nandurkar H, Ho P. Overall Haemostatic Potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients. J Thromb Thrombolysis. 2022;55:32\u201341.","journal-title":"J Thromb Thrombolysis"},{"key":"3651_CR118","first-page":"e219","volume":"44","author":"N Lee","year":"2022","unstructured":"Lee N, Wang J, Brook R, Monagle P, Donnan G, Nandurkar H, et al. The evaluation of overall hemostatic potential assay in patients with COVID-19 infection. Int J Lab Hematol. 2022;44:e219\u201323.","journal-title":"Int J Lab Hematol"},{"key":"3651_CR119","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3390\/jpm12101711","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Choy KW, Lim HY, Ho P. Impaired fibrinolytic potential predicts oxygen requirement in COVID-19. J Personalized Medicine. 2022;12:1711.","journal-title":"J Personalized Medicine"},{"key":"3651_CR120","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/ijms23073636","volume":"23","author":"A Buonacera","year":"2022","unstructured":"Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022;23:3636.","journal-title":"Int J Mol Sci"},{"key":"3651_CR121","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.3324\/haematol.2016.145151","volume":"101","author":"G Grimnes","year":"2016","unstructured":"Grimnes G, Horvei LD, Tichelaar V, Br\u00e6kkan SK, Hansen J-B. Neutrophil to lymphocyte ratio and future risk of venous thromboembolism and mortality: the Troms\u00f8 Study. Haematologica. 2016;101:e401\u20134.","journal-title":"Haematologica"},{"key":"3651_CR122","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/MEG.0000000000001982","volume":"33","author":"F Nery","year":"2021","unstructured":"Nery F, Carneiro P, Correia S, Macedo C, Gandara J, Lopes V, et al. Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study. Eur J Gastroenterol Hepatol. 2021;33:e108\u201313.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3651_CR123","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jvs.2009.05.059","volume":"50","author":"N Labropoulos","year":"2009","unstructured":"Labropoulos N, Gasparis AP, Tassiopoulos AK. Prospective evaluation of the clinical deterioration in post-thrombotic limbs. J Vasc Surg. 2009;50:826\u201330.","journal-title":"J Vasc Surg"},{"key":"3651_CR124","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1182\/blood-2018-03-836783","volume":"132","author":"EE Amin","year":"2018","unstructured":"Amin EE, Bistervels IM, Meijer K, Tick LW, Middeldorp S, Mostard G, et al. Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis. Blood. 2018;132:2298\u2013304.","journal-title":"Blood"},{"key":"3651_CR125","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1055\/s-0038-1655743","volume":"118","author":"E Amin","year":"2018","unstructured":"Amin E, van Kuijk S, Joore M, Prandoni P, ten Cate H, ten Cate-Hoek A. Development and validation of a practical two-step prediction model and clinical risk score for post-thrombotic syndrome. Thromb Haemostasis. 2018;118:1242\u20139.","journal-title":"Thromb Haemostasis"},{"key":"3651_CR126","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.surg.2019.05.030","volume":"166","author":"RA Soares","year":"2019","unstructured":"Soares RA, Matielo MF, Neto FCB, Nogueira MP, Almeida RD, Sacilotto R. Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin. Surgery. 2019;166:1076\u201383.","journal-title":"Surgery."},{"key":"3651_CR127","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11739-019-02215-z","volume":"15","author":"P Prandoni","year":"2020","unstructured":"Prandoni P, Ageno W, Ciammaichella M, Mumoli N, Zanatta N, Imberti D, et al. The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants. Intern Emerg Med. 2020;15:447\u201352.","journal-title":"Intern Emerg Med"},{"key":"3651_CR128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.thromres.2017.05.029","volume":"157","author":"L Jeraj","year":"2017","unstructured":"Jeraj L, Jezovnik MK, Poredos P. Rivaroxaban versus warfarin in the prevention of post-thrombotic syndrome. Thromb Res. 2017;157:46\u20138.","journal-title":"Thromb Res"},{"key":"3651_CR129","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1076029618758955","volume":"24","author":"CI Coleman","year":"2018","unstructured":"Coleman CI, Beyer-Westendorf J, Bunz TJ, Mahan CE, Spyropoulos AC. Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism. Clin Appl Thrombosis Hemostasis. 2018;24:575\u201382.","journal-title":"Clin Appl Thrombosis Hemostasis"},{"key":"3651_CR130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.thromres.2018.01.013","volume":"163","author":"KK Utne","year":"2018","unstructured":"Utne KK, Dahm A, Wik HS, Jelsness-J\u00f8rgensen LP, Sandset PM, Ghanima W. Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome. Thromb Res. 2018;163:6\u201311.","journal-title":"Thromb Res"},{"key":"3651_CR131","doi-asserted-by":"crossref","first-page":"106608","DOI":"10.1016\/j.vph.2019.106608","volume":"124","author":"T Ferreira","year":"2020","unstructured":"Ferreira T, Huber SC, Martinelli BM, Junior AL, Menezes FH, Orsi FA, et al. Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban. Vasc Pharmacol. 2020;124:106608.","journal-title":"Vasc Pharmacol."},{"key":"3651_CR132","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1160\/TH16-01-0041","volume":"116","author":"YW Cheung","year":"2016","unstructured":"Cheung YW, Middeldorp S, Prins MH, Pap AF, Lensing AWA, Cate-Hoek AJT, et al. Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin\/vitamin K antagonists for acute deep-vein thrombosis. Thromb Haemostasis. 2016;116:733\u20138.","journal-title":"Thromb Haemostasis"},{"key":"3651_CR133","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jvsv.2021.06.023","volume":"10","author":"X Yang","year":"2022","unstructured":"Yang X, Zhang X, Yin M, Wang R, Lu X, Ye K. Elastic compression stockings to prevent post-thrombotic syndrome in proximal deep venous thrombosis patients without thrombus removal. J Vasc Surg Venous Lymphatic Disord. 2022;10:293\u20139.","journal-title":"J Vasc Surg Venous Lymphatic Disord"},{"key":"3651_CR134","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1055\/s-0038-1661392","volume":"118","author":"M M\u00e9an","year":"2018","unstructured":"M\u00e9an M, Limacher A, Alatri A, Aujesky D, Mazzolai L. Derivation and validation of a prediction model for risk stratification of post-thrombotic syndrome in elderly patients with a first deep vein thrombosis. Thromb Haemostasis. 2018;118:1419\u201327.","journal-title":"Thromb Haemostasis"},{"key":"3651_CR135","doi-asserted-by":"crossref","first-page":"12663","DOI":"10.1038\/s41598-018-30645-w","volume":"8","author":"H Huang","year":"2018","unstructured":"Huang H, Gu J-P, Shi H-F, Shi W-Y, Lu J-Y, Chen L, et al. Assessment of the probability of post-thrombotic syndrome in patients with lower extremity deep venous thrombosis. Sci Rep-uk. 2018;8:12663.","journal-title":"Sci Rep-uk"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03651-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-023-03651-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03651-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T03:23:46Z","timestamp":1698722626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-023-03651-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":135,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["3651"],"URL":"https:\/\/doi.org\/10.1007\/s12185-023-03651-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"24 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}